Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 199 entries
Sorted by: Best Match Show Resources per page
Hydralazine-selective PVC membrane electrode based on hydralazinium tetraphenylborate.

Talanta

Badawy SS, Shoukry AF, Rizk MS, Omar MM.
PMID: 18964557
Talanta. 1988 Jun;35(6):487-9. doi: 10.1016/0039-9140(88)80113-9.

A hydralazine ion-selective PVC membrane electrode based on hydralazinium tetraphenylborate has been prepared with dioctyl phthalate as plasticizer. The electrode showed linear response with a slope factor of 57.5 mV/concentration decade at 20 degrees over the concentration range from...

Cite
Badawy SS, Shoukry AF, Rizk MS, et al. Hydralazine-selective PVC membrane electrode based on hydralazinium tetraphenylborate. Talanta. 1988;35(6):487-9doi: 10.1016/0039-9140(88)80113-9.
Badawy, S. S., Shoukry, A. F., Rizk, M. S., & Omar, M. M. (1988). Hydralazine-selective PVC membrane electrode based on hydralazinium tetraphenylborate. Talanta, 35(6), 487-9. https://doi.org/10.1016/0039-9140(88)80113-9
Badawy, S S, et al. "Hydralazine-selective PVC membrane electrode based on hydralazinium tetraphenylborate." Talanta vol. 35,6 (1988): 487-9. doi: https://doi.org/10.1016/0039-9140(88)80113-9
Badawy SS, Shoukry AF, Rizk MS, Omar MM. Hydralazine-selective PVC membrane electrode based on hydralazinium tetraphenylborate. Talanta. 1988 Jun;35(6):487-9. doi: 10.1016/0039-9140(88)80113-9. PMID: 18964557.
Copy Download .nbib Format: NLM
Kinetic study of the determination of hydrazines, isoniazid and sodium azide by monitoring their reactions with 1-fluoro-2,4-dinitrobenzene, by means of a fluoride-selective electrode.

Talanta

Athanasiou-Malaki E, Koupparis MA.
PMID: 18964734
Talanta. 1989 Apr;36(4):431-6. doi: 10.1016/0039-9140(89)80224-3.

A kinetic potentiometric method is described for the determination of hydrazines (hydrazine, phenylhydrazine, hydralazine and procarbazine), isoniazid and sodium azide, based on monitoring their reactions at 25 degrees and pH 9.0 with 1-fluoro-2,4-dinitrobenzene by means of a fluoride-selective electrode....

Cite
Athanasiou-Malaki E, Koupparis MA. Kinetic study of the determination of hydrazines, isoniazid and sodium azide by monitoring their reactions with 1-fluoro-2,4-dinitrobenzene, by means of a fluoride-selective electrode. Talanta. 1989;36(4):431-6doi: 10.1016/0039-9140(89)80224-3.
Athanasiou-Malaki, E., & Koupparis, M. A. (1989). Kinetic study of the determination of hydrazines, isoniazid and sodium azide by monitoring their reactions with 1-fluoro-2,4-dinitrobenzene, by means of a fluoride-selective electrode. Talanta, 36(4), 431-6. https://doi.org/10.1016/0039-9140(89)80224-3
Athanasiou-Malaki, E, and Koupparis, M A. "Kinetic study of the determination of hydrazines, isoniazid and sodium azide by monitoring their reactions with 1-fluoro-2,4-dinitrobenzene, by means of a fluoride-selective electrode." Talanta vol. 36,4 (1989): 431-6. doi: https://doi.org/10.1016/0039-9140(89)80224-3
Athanasiou-Malaki E, Koupparis MA. Kinetic study of the determination of hydrazines, isoniazid and sodium azide by monitoring their reactions with 1-fluoro-2,4-dinitrobenzene, by means of a fluoride-selective electrode. Talanta. 1989 Apr;36(4):431-6. doi: 10.1016/0039-9140(89)80224-3. PMID: 18964734.
Copy Download .nbib Format: NLM
The African-American heart failure trial: a new look at old drugs.

Future cardiology

Felker GM.
PMID: 19804113
Future Cardiol. 2005 May;1(3):311-3. doi: 10.1517/14796678.1.3.311.

Evaluation of: Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. Taylor AL, Zieche S, Yancy C et al.: N. Engl. J. Med. 351, 2049-2057 (2004). The African-American Heart Failure Trial (AHeFT) evaluated the efficacy of a...

Cite
Felker GM. The African-American heart failure trial: a new look at old drugs. Future Cardiol. 2005;1(3):311-3doi: 10.1517/14796678.1.3.311.
Felker, G. M. (2005). The African-American heart failure trial: a new look at old drugs. Future cardiology, 1(3), 311-3. https://doi.org/10.1517/14796678.1.3.311
Felker, G Michael. "The African-American heart failure trial: a new look at old drugs." Future cardiology vol. 1,3 (2005): 311-3. doi: https://doi.org/10.1517/14796678.1.3.311
Felker GM. The African-American heart failure trial: a new look at old drugs. Future Cardiol. 2005 May;1(3):311-3. doi: 10.1517/14796678.1.3.311. PMID: 19804113.
Copy Download .nbib Format: NLM
Chitosan nanoparticle-based neuronal membrane sealing and neuroprotection following acrolein-induced cell injury.

Journal of biological engineering

Cho Y, Shi R, Ben Borgens R.
PMID: 20205817
J Biol Eng. 2010 Jan 29;4(1):2. doi: 10.1186/1754-1611-4-2.

BACKGROUND: The highly reactive aldehyde acrolein is a very potent endogenous toxin with a long half-life. Acrolein is produced within cells after insult, and is a central player in slow and progressive "secondary injury" cascades. Indeed, acrolein-biomolecule complexes formed...

Cite
Cho Y, Shi R, Ben Borgens R. Chitosan nanoparticle-based neuronal membrane sealing and neuroprotection following acrolein-induced cell injury. J Biol Eng. 2010;4(1):2doi: 10.1186/1754-1611-4-2.
Cho, Y., Shi, R., & Ben Borgens, R. (2010). Chitosan nanoparticle-based neuronal membrane sealing and neuroprotection following acrolein-induced cell injury. Journal of biological engineering, 4(1), 2. https://doi.org/10.1186/1754-1611-4-2
Cho, Youngnam, et al. "Chitosan nanoparticle-based neuronal membrane sealing and neuroprotection following acrolein-induced cell injury." Journal of biological engineering vol. 4,1 (2010): 2. doi: https://doi.org/10.1186/1754-1611-4-2
Cho Y, Shi R, Ben Borgens R. Chitosan nanoparticle-based neuronal membrane sealing and neuroprotection following acrolein-induced cell injury. J Biol Eng. 2010 Jan 29;4(1):2. doi: 10.1186/1754-1611-4-2. PMID: 20205817; PMCID: PMC2824642.
Copy Download .nbib Format: NLM
Effects of angiotensin II receptor blockade on glucose metabolism via AMP-activated protein kinase in insulin-resistant hypertensive rats.

Journal of the American Society of Hypertension : JASH

Yoshida D, Higashiura K, Shinshi Y, Satoh K, Hyakkoku M, Yoshida H, Miyazaki Y, Ura N, Shimamoto K.
PMID: 20409939
J Am Soc Hypertens. 2009 Jan-Feb;3(1):3-8. doi: 10.1016/j.jash.2008.08.002. Epub 2008 Oct 31.

AMP-activated protein kinase (AMPK) mediates metabolic responses of muscle to exercise and is involved in improvement of insulin resistance by endurance exercise. Recent studies have suggested that the renin-angiotensin system (RAS) might negatively modulate insulin-mediated actions, but there has...

Cite
Yoshida D, Higashiura K, Shinshi Y, et al. Effects of angiotensin II receptor blockade on glucose metabolism via AMP-activated protein kinase in insulin-resistant hypertensive rats. J Am Soc Hypertens. 2008;3(1):3-8doi: 10.1016/j.jash.2008.08.002.
Yoshida, D., Higashiura, K., Shinshi, Y., Satoh, K., Hyakkoku, M., Yoshida, H., Miyazaki, Y., Ura, N., & Shimamoto, K. (2009). Effects of angiotensin II receptor blockade on glucose metabolism via AMP-activated protein kinase in insulin-resistant hypertensive rats. Journal of the American Society of Hypertension : JASH, 3(1), 3-8. https://doi.org/10.1016/j.jash.2008.08.002
Yoshida, Daisuke, et al. "Effects of angiotensin II receptor blockade on glucose metabolism via AMP-activated protein kinase in insulin-resistant hypertensive rats." Journal of the American Society of Hypertension : JASH vol. 3,1 (2009): 3-8. doi: https://doi.org/10.1016/j.jash.2008.08.002
Yoshida D, Higashiura K, Shinshi Y, Satoh K, Hyakkoku M, Yoshida H, Miyazaki Y, Ura N, Shimamoto K. Effects of angiotensin II receptor blockade on glucose metabolism via AMP-activated protein kinase in insulin-resistant hypertensive rats. J Am Soc Hypertens. 2009 Jan-Feb;3(1):3-8. doi: 10.1016/j.jash.2008.08.002. Epub 2008 Oct 31. PMID: 20409939.
Copy Download .nbib Format: NLM
Congenital mesoblastic nephroma: a case report.

Journal of family & community medicine

Al-Turkistani HK.
PMID: 23012173
J Family Community Med. 2008 May;15(2):91-3.

Congenital mesoblastic nephroma (CMN) is a rare renal tumor. It can be detected antenatally especially with judicious use of ultrasonography.A premature female neonate 28 weeks' gestation, complicated by polyhydramnios, was born to a 28-year-old woman. An abdominal mass was...

Cite
Al-Turkistani HK. Congenital mesoblastic nephroma: a case report. J Family Community Med. 2008;15(2):91-3
Al-Turkistani, H. K. (2008). Congenital mesoblastic nephroma: a case report. Journal of family & community medicine, 15(2), 91-3.
Al-Turkistani, Hatim K. "Congenital mesoblastic nephroma: a case report." Journal of family & community medicine vol. 15,2 (2008): 91-3.
Al-Turkistani HK. Congenital mesoblastic nephroma: a case report. J Family Community Med. 2008 May;15(2):91-3. PMID: 23012173; PMCID: PMC3377027.
Copy Download .nbib Format: NLM
Acrolein as a novel therapeutic target for motor and sensory deficits in spinal cord injury.

Neural regeneration research

Park J, Muratori B, Shi R.
PMID: 25206871
Neural Regen Res. 2014 Apr 01;9(7):677-83. doi: 10.4103/1673-5374.131564.

IN THE HOURS TO WEEKS FOLLOWING TRAUMATIC SPINAL CORD INJURIES (SCI), BIOCHEMICAL PROCESSES ARE INITIATED THAT FURTHER DAMAGE THE TISSUE WITHIN AND SURROUNDING THE INITIAL INJURY SITE: a process termed secondary injury. Acrolein, a highly reactive unsaturated aldehyde, has...

Cite
Park J, Muratori B, Shi R. Acrolein as a novel therapeutic target for motor and sensory deficits in spinal cord injury. Neural Regen Res. 2014;9(7):677-83doi: 10.4103/1673-5374.131564.
Park, J., Muratori, B., & Shi, R. (2014). Acrolein as a novel therapeutic target for motor and sensory deficits in spinal cord injury. Neural regeneration research, 9(7), 677-83. https://doi.org/10.4103/1673-5374.131564
Park, Jonghyuck, et al. "Acrolein as a novel therapeutic target for motor and sensory deficits in spinal cord injury." Neural regeneration research vol. 9,7 (2014): 677-83. doi: https://doi.org/10.4103/1673-5374.131564
Park J, Muratori B, Shi R. Acrolein as a novel therapeutic target for motor and sensory deficits in spinal cord injury. Neural Regen Res. 2014 Apr 01;9(7):677-83. doi: 10.4103/1673-5374.131564. PMID: 25206871; PMCID: PMC4146266.
Copy Download .nbib Format: NLM
Stability of hydralazine hydrochloride in both flavored and non- flavored extemporaneous preparations.

International journal of pharmaceutical compounding

Okeke CC, Medwick T, Nairn G, Khuspe S, Grady LT.
PMID: 23979703
Int J Pharm Compd. 2003 Jul-Aug;7(4):313-9.

The objective of this study was to evaluate the chemical stability of hydralazine hydrochloride 0.1% and 1% when prepared extemporaneously from commercially available hydralazine bulk powder. The oral solutions were prepared to contain preservatives, sweeteners, a humectant and diluting...

Cite
Okeke CC, Medwick T, Nairn G, et al. Stability of hydralazine hydrochloride in both flavored and non- flavored extemporaneous preparations. Int J Pharm Compd. 2003;7(4):313-9
Okeke, C. C., Medwick, T., Nairn, G., Khuspe, S., & Grady, L. T. (2003). Stability of hydralazine hydrochloride in both flavored and non- flavored extemporaneous preparations. International journal of pharmaceutical compounding, 7(4), 313-9.
Okeke, Claudia C, et al. "Stability of hydralazine hydrochloride in both flavored and non- flavored extemporaneous preparations." International journal of pharmaceutical compounding vol. 7,4 (2003): 313-9.
Okeke CC, Medwick T, Nairn G, Khuspe S, Grady LT. Stability of hydralazine hydrochloride in both flavored and non- flavored extemporaneous preparations. Int J Pharm Compd. 2003 Jul-Aug;7(4):313-9. PMID: 23979703.
Copy Download .nbib Format: NLM
Attenuation of Immune-Mediated Renal Injury by Telmisartan, an Angiotensin Receptor Blocker and a Selective PPAR-γ Activator.

Nephron extra

Hamano Y, Okude T, Yokosuka O, Ogawa M.
PMID: 22470382
Nephron Extra. 2011 Jan;1(1):78-90. doi: 10.1159/000331704. Epub 2011 Sep 22.

BACKGROUND/AIMS: Anti-glomerular basement membrane (GBM) nephritis is characterized by activation of the renin-angiotensin system. This study aimed to determine the question of whether a temporary angiotensin II blockade at the initial stage of anti-GBM nephritis is able to attenuate...

Cite
Hamano Y, Okude T, Yokosuka O, et al. Attenuation of Immune-Mediated Renal Injury by Telmisartan, an Angiotensin Receptor Blocker and a Selective PPAR-γ Activator. Nephron Extra. 2011;1(1):78-90doi: 10.1159/000331704.
Hamano, Y., Okude, T., Yokosuka, O., & Ogawa, M. (2011). Attenuation of Immune-Mediated Renal Injury by Telmisartan, an Angiotensin Receptor Blocker and a Selective PPAR-γ Activator. Nephron extra, 1(1), 78-90. https://doi.org/10.1159/000331704
Hamano, Yuki, et al. "Attenuation of Immune-Mediated Renal Injury by Telmisartan, an Angiotensin Receptor Blocker and a Selective PPAR-γ Activator." Nephron extra vol. 1,1 (2011): 78-90. doi: https://doi.org/10.1159/000331704
Hamano Y, Okude T, Yokosuka O, Ogawa M. Attenuation of Immune-Mediated Renal Injury by Telmisartan, an Angiotensin Receptor Blocker and a Selective PPAR-γ Activator. Nephron Extra. 2011 Jan;1(1):78-90. doi: 10.1159/000331704. Epub 2011 Sep 22. PMID: 22470382; PMCID: PMC3290842.
Copy Download .nbib Format: NLM
Association of Sweet's Syndrome and Systemic Lupus Erythematosus.

Case reports in rheumatology

Barton JL, Pincus L, Yazdany J, Richman N, McCalmont TH, Gensler L, Dall'era M, Fye KH.
PMID: 22937442
Case Rep Rheumatol. 2011;2011:242681. doi: 10.1155/2011/242681. Epub 2011 Nov 14.

Sweet's syndrome is an acute febrile neutrophilic dermatosis which usually presents as an idiopathic disorder but can also be drug induced, associated with hematopoetic malignancies and myelodysplastic disorders, and more, infrequently, observed in autoimmune disorders. Sweet's syndrome has been...

Cite
Barton JL, Pincus L, Yazdany J, et al. Association of Sweet's Syndrome and Systemic Lupus Erythematosus. Case Rep Rheumatol. 2011;2011:242681doi: 10.1155/2011/242681.
Barton, J. L., Pincus, L., Yazdany, J., Richman, N., McCalmont, T. H., Gensler, L., Dall'era, M., & Fye, K. H. (2011). Association of Sweet's Syndrome and Systemic Lupus Erythematosus. Case reports in rheumatology, 2011242681. https://doi.org/10.1155/2011/242681
Barton, J L, et al. "Association of Sweet's Syndrome and Systemic Lupus Erythematosus." Case reports in rheumatology vol. 2011 (2011): 242681. doi: https://doi.org/10.1155/2011/242681
Barton JL, Pincus L, Yazdany J, Richman N, McCalmont TH, Gensler L, Dall'era M, Fye KH. Association of Sweet's Syndrome and Systemic Lupus Erythematosus. Case Rep Rheumatol. 2011;2011:242681. doi: 10.1155/2011/242681. Epub 2011 Nov 14. PMID: 22937442; PMCID: PMC3420725.
Copy Download .nbib Format: NLM
Outcomes of hydralazine induced renal vasculitis.

European journal of rheumatology

Timlin H, Liebowitz JE, Jaggi K, Geetha D.
PMID: 29657868
Eur J Rheumatol. 2018 Mar;5(1):5-8. doi: 10.5152/eurjrheum.2017.17075. Epub 2017 Dec 07.

OBJECTIVE: Hydralazine has been implicated as an etiologic agent for lupus-like syndrome and vasculitis. Hydralazine-induced vasculitis frequently affects the kidney, but the long-term renal outcomes in these patients have not yet been studied.METHODS: Patients who had a diagnosis of...

Cite
Timlin H, Liebowitz JE, Jaggi K, et al. Outcomes of hydralazine induced renal vasculitis. Eur J Rheumatol. 2017;5(1):5-8doi: 10.5152/eurjrheum.2017.17075.
Timlin, H., Liebowitz, J. E., Jaggi, K., & Geetha, D. (2018). Outcomes of hydralazine induced renal vasculitis. European journal of rheumatology, 5(1), 5-8. https://doi.org/10.5152/eurjrheum.2017.17075
Timlin, Homa, et al. "Outcomes of hydralazine induced renal vasculitis." European journal of rheumatology vol. 5,1 (2018): 5-8. doi: https://doi.org/10.5152/eurjrheum.2017.17075
Timlin H, Liebowitz JE, Jaggi K, Geetha D. Outcomes of hydralazine induced renal vasculitis. Eur J Rheumatol. 2018 Mar;5(1):5-8. doi: 10.5152/eurjrheum.2017.17075. Epub 2017 Dec 07. PMID: 29657868; PMCID: PMC5895152.
Copy Download .nbib Format: NLM
Adsorptive Behavior and Voltammetric Determination of Hydralazine Hydrochloride at A Glassy Carbon Electrode Modified with Multiwalled Carbon Nanotubes.

Iranian journal of pharmaceutical research : IJPR

Khodadadian M, Jalili R, Bahrami MT, Bahrami G.
PMID: 29552043
Iran J Pharm Res. 2017;16(4):1312-1319.

An electroanalytical method has been introduced for highly sensitive determination of hydralazine hydrochloride (Hy-HCl) based on its oxidation at a glassy carbon electrode modified with multiwalled carbon nanotubes (MWCNT/GCE). Studies showed that the electrochemical oxidation of Hy-HCl was accompanied...

Cite
Khodadadian M, Jalili R, Bahrami MT, et al. Adsorptive Behavior and Voltammetric Determination of Hydralazine Hydrochloride at A Glassy Carbon Electrode Modified with Multiwalled Carbon Nanotubes. Iran J Pharm Res. 2017;16(4):1312-1319
Khodadadian, M., Jalili, R., Bahrami, M. T., & Bahrami, G. (2017). Adsorptive Behavior and Voltammetric Determination of Hydralazine Hydrochloride at A Glassy Carbon Electrode Modified with Multiwalled Carbon Nanotubes. Iranian journal of pharmaceutical research : IJPR, 16(4), 1312-1319.
Khodadadian, Mehdi, et al. "Adsorptive Behavior and Voltammetric Determination of Hydralazine Hydrochloride at A Glassy Carbon Electrode Modified with Multiwalled Carbon Nanotubes." Iranian journal of pharmaceutical research : IJPR vol. 16,4 (2017): 1312-1319.
Khodadadian M, Jalili R, Bahrami MT, Bahrami G. Adsorptive Behavior and Voltammetric Determination of Hydralazine Hydrochloride at A Glassy Carbon Electrode Modified with Multiwalled Carbon Nanotubes. Iran J Pharm Res. 2017;16(4):1312-1319. PMID: 29552043; PMCID: PMC5843295.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 199 entries